Q2 sales came in at SEK 1,710m (+5% vs. ABGSCe 1,627m), EBITA at SEK 129m (in line with ABGSCe 129m) and adj. EBITA at SEK 141m (+9% vs. ABGSCe 129m). Reported organic growth was +13% vs ABGSCe +16%, suggesting a marginal deceleration in organic growth as the company shifts focus to integrating some of the larger businesses in the group and improving operating efficiency. M&A-related growth was +60% and FX contribution was +2%, respectively. Operating cash flow was much better than expected, even after deducting for NRIs from tax deferrals.
